TheEdgeResearch
Home / Stocks / BINP

Bionoid Pharma, Inc. (BINP)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.03 ▼ -0.00%
Market Cap
$1.6M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-4.66
52-Wk Range
0.0162-0.448
CEO
Patricia Colvin
Country
US
Currency
USD

Bionoid Pharma, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Beverly Hills, CA, US. The stock last traded at $0.03, down 0.00% on the session, giving a market capitalisation of $1.6M. On trailing twelve-month figures it carries a trailing P/E of -3.53, a net margin of 0.0%. Its beta of -4.66 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.53
Price / Sales
0.00
Price / Book
0.41
EV / EBITDA
-14.83
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2007-06-29
Headquarters
Beverly Hills, CA, US
About Bionoid Pharma, Inc.

Bionoid Pharma, Inc. functions as a medical technology enterprise. This company concentrates on the creation and commercialization of advanced medical instruments and solutions, primarily targeting the orthopedic and pain management industries. Founded on October 20, 1997, its corporate headquarters are situated in Beverly Hills, California.

Comparable companies

Bionoid Pharma, Inc. is most often compared with the following Healthcare names:

BMCSBMMJCBDYCTTHEDXCEXMTHBRMLVVEFMJNASRUTF
More research on BINP
BINP technical analysis BINP TheEdge Score Compare against peers
Open full interactive analysis & DCF →